We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.4B
AUM Growth
-$180M
(-11%)
Cap. Flow
-$897M
Cap. Flow
% of AUM
-63.84%
Top 10 Holdings %
Top 10 Hldgs %
35.82%
Holding
285
New
71
Increased
30
Reduced
16
Closed
59
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.5
years
Top 20 Avg Time Held Equity + Options
0.6
years
Avg Time Held Equity only
0.5
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$19M |
| 2 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$15.7M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$14.8M |
| 4 |
PSB
PS Business Parks, Inc.
PSB
|
+$12.8M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$9.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MIME
Mimecast Limited
MIME
|
+$13.5M |
| 2 |
CERN
Cerner Corp
CERN
|
+$13.1M |
| 3 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$11.1M |
| 4 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
+$10.5M |
| 5 |
PLAN
Anaplan, Inc.
PLAN
|
+$7.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.81% |
| 2 | Financials | 5.68% |
| 3 | Technology | 4.91% |
| 4 | Communication Services | 3.05% |
| 5 | Real Estate | 2.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
PUT
Patrick Industries
PATK
$2.24B
| $1.29M | 0.09% |
+37,500
| New | +$1.48M |
2022 Q2
0 quarters
|
|
77
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.26M | 0.09% |
+10,000
| New | +$1.15M |
2022 Q2
0 quarters
|
|
|
78
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.26M | 0.09% |
+10,000
| New | +$1.15M |
2022 Q2
0 quarters
|
|
79
Under Armour
UAA
$2.12B
| $1.25M | 0.09% |
150,000
+50,000
| +50% | +$613K |
2021 Q3
3 quarters
|
|
|
CVET
80
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.19M | 0.08% |
+57,409
| New | +$1.02M |
2022 Q2
0 quarters
|
|
|
TWTR
81
PUT
DELISTED
Twitter, Inc.
TWTR
| $1.12M | 0.08% |
+30,000
| New | +$1.29M |
2022 Q2
0 quarters
|
|
82
PUT
JBT Marel
JBTM
$5.52B
| $1.1M | 0.08% |
+10,000
| New | +$1.15M |
2022 Q2
0 quarters
|
|
83
PUT
BILL Holdings
BILL
$3.88B
| $1.1M | 0.08% |
+10,000
| New | +$1.46M |
2022 Q2
0 quarters
|
|
|
MNDT
84
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.09M | 0.08% |
50,000
| – | – |
2022 Q1
1 quarter
|
|
|
ATCO
85
PUT
DELISTED
Atlas Corp.
ATCO
| $1.07M | 0.08% |
100,000
-181,000
| -64% | -$2.27M |
2021 Q4
2 quarters
|
|
86
PUT
Upwork
UPWK
$1.06B
| $1.03M | 0.07% |
+50,000
| New | +$983K |
2022 Q2
0 quarters
|
|
87
BioMarin Pharmaceuticals
BMRN
$10.7B
| $1.01M | 0.07% |
+12,200
| New | +$971K |
2022 Q2
0 quarters
|
|
88
PUT
DELISTED
Anywhere Real Estate
HOUS
| $982K | 0.07% |
100,000
-210,000
| -68% | -$2.47M |
2021 Q3
3 quarters
|
|
89
Celldex Therapeutics
CLDX
$2.23B
| $971K | 0.07% |
36,000
+28,300
| +368% | +$822K |
2022 Q1
1 quarter
|
|
|
90
PUT
Celldex Therapeutics
CLDX
$2.23B
| $971K | 0.07% |
+36,000
| New | +$1.05M |
2022 Q2
0 quarters
|
|
|
AMRS
91
PUT
DELISTED
Amyris Inc.
AMRS
| $956K | 0.07% |
515,000
-1,303,700
| -72% | -$3.84M |
2021 Q4
2 quarters
|
|
|
92
Upwork
UPWK
$1.06B
| $943K | 0.07% |
+45,600
| New | +$896K |
2022 Q2
0 quarters
|
|
|
CFRX
93
PUT
DELISTED
ContraFect Corporation
CFRX
| $931K | 0.07% |
+3,829
| New | +$1.08M |
2022 Q2
0 quarters
|
|
|
MDRX
94
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
| $890K | 0.06% |
+60,000
| New | +$1.12M |
2022 Q2
0 quarters
|
|
95
CALL
Pliant Therapeutics
PLRX
$59.3M
| $881K | 0.06% |
+110,000
| New | +$704K |
2022 Q2
0 quarters
|
|
96
CALL
Booking.com
BKNG
$125B
| $875K | 0.06% |
12,500
| – | – |
2022 Q1
1 quarter
|
|
97
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $855K | 0.06% |
86,500
| – | – |
2021 Q4
2 quarters
|
|
|
98
PUT
BioMarin Pharmaceuticals
BMRN
$10.7B
| $829K | 0.06% |
+10,000
| New | +$796K |
2022 Q2
0 quarters
|
|
99
PUT
CNX Resources
CNX
$5.24B
| $823K | 0.06% |
+50,000
| New | +$1.02M |
2022 Q2
0 quarters
|
|
100
CALL
Travere Therapeutics
TVTX
$4.73B
| $793K | 0.06% |
+32,700
| New | +$822K |
2022 Q2
0 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, DLD Asset Management held 285 positions worth $1.4B, down 11% from $1.58B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
DLD Asset Management withdrew a net $897M in Q2 2022, closing 59 positions and reducing 16 holdings. Its most notable exit was Mimecast Limited, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 80% a quarter earlier, followed by Financials and Technology.
Against the trend, DLD Asset Management opened a new position in American Campus Communities, Inc. worth $19.3M.
- DLD Asset Management's largest Q2 2022 buy was American Campus Communities, Inc.: 300,000 shares worth $19.3M.
- DLD Asset Management added most to Plantronics, Inc. in Q2 2022, an estimated $5.16M increase.
- DLD Asset Management's biggest Q2 2022 reduction was Healthcare Realty, cutting an estimated $4.68M.
- DLD Asset Management fully exited Mimecast Limited in Q2 2022, selling an estimated $13.5M.
- DLD Asset Management's ten largest holdings make up 36% of its $1.4B portfolio in Q2 2022.
- DLD Asset Management opened 71 new positions and closed 59 in Q2 2022.
- DLD Asset Management's portfolio value fell 11% quarter-over-quarter to $1.4B.
Based on DLD Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.